MERS-CoV: clinical management and guidance
Guidance on investigating Middle East respiratory syndrome coronavirus (MERS-CoV), public health management of suspected UK cases and advice to travellers.
MERS-CoV is a zoonotic respiratory virus and the causative agent of Middle East respiratory syndrome (MERS). MERS-CoV is a coronavirus, first identified in Saudi Arabia in 2012. A similar strain in the UK was identified by Public Heath England’s (PHE) virus reference laboratories at Colindale, now UK Health Security Agency (UKHSA) Colindale. The virus was fully sequenced and detailed analysis indicates that the nearest relatives are bat coronaviruses.
Symptoms include fever and cough that progress to a severe pneumonia causing shortness of breath and breathing difficulties. In some cases, a diarrheal illness has been the first symptom to appear.
There is currently no vaccine available for MERS-CoV.
Healthcare professionals should refer to National infection prevention and control manual (NIPCM) for England published by NHS England.